Summit Medical Group PA

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Multiple myeloma1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 1/22 trials
• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• BioNTech SE2 trials
• Cullinan Therapeutics Inc.1 trial
• Teva Branded Pharmaceutical Products R&D LLC1 trial

Running trials

• Recruiting

  ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  NCT07173751· Phase 3· BioNTech SE· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· BioNTech SE· Source

• Active, not recruiting

  A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

  NCT04036682· Phase 1/2· Cullinan Therapeutics Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

  NCT05590377· Phase 1/2· Teva Branded Pharmaceutical Products R&D LLC· Source